Leadership
The foundation’s leaders come from a broad range of backgrounds and have a diversity of expertise and experience that spans science and technology, medicine, public policy, education, communications, law, and business. Our leaders are guided by the foundation’s mission to create a world in which every person has the opportunity to live a healthy, productive life.
Executive Leadership
Chair and Governing Board
Scientific Advisory Committee
Our Scientific Advisory Committee comprises a group of esteemed experts from outside of the foundation who offer a wide range of experiences and perspectives. This group plays an important role in strengthening our work by offering independent assessments of our Global Health Division strategies and helping us evaluate results.
Meet our leaders
-

Lynda Stuart
Former Deputy Director, Vaccines & Human Immunology
Dr. Lynda Stuart led the Vaccine and Host Pathogen Biology domain of the Discovery and Translational Sciences team.
-

Maike Scharp
Deputy Director, Diagnostics
Dr. Maike Scharp leads the foundation’s efforts to support development of diagnostic tools and devices and end-to-end diagnostic platforms for enteric and diarrheal diseases.
-

Marlo Hartung
Deputy Director, Strategy, Planning, and Management
Marlo Hartung leads strategy implementation, financial portfolio management and business operations for the EDGE team which is focused on reducing the burden of enteric diseases and improving access to cutting edge diagnostic and disease surveillance technologies in the developing world.
-

Mike McCune
Head of HIV Frontiers, Accelerator
Mike McCune leads a team that works to develop novel gene-based curative interventions for HIV and sickle cell disease.
-

Murray M. Lumpkin
Deputy Director, Regulatory
Dr. Murray (“Mac”) Lumpkin leads the Integrated Development team’s efforts to strengthen regulatory systems governing the development, marketing, and procurement of health products in low- and middle-income countries.
-

Nina Russell
Director, TB & HIV Research and Development
Dr. Nina Russell oversees the foundation’s investments in vaccine and drug development to prevent and treat tuberculosis (TB) and HIV.
-

Obinna Onyekwena
Deputy Director, Infectious Diseases Advocacy, Program Advocacy & Communications
Dr. Obinna (Obi) Onyekwena leads the foundation’s infectious disease advocacy work and its investments to advance financing and policy goals related to HIV, tuberculosis, malaria, neglected tropical diseases, and the Global Fund to Fight AIDS, Tuberculosis and Malaria.
-

Padmini Srikantiah
Deputy Director, Pneumonia
Dr. Padmini Srikantiah leads the foundation’s initiative to address respiratory syncytial virus, the chief cause of pneumonia in young infants globally, as well as the cross-foundation antimicrobial resistance strategy, which includes efforts to prevent newborn sepsis.
-

Pervin Anklesaria
Deputy Director, HIV and Tuberculosis
Pervin Anklesaria leads the HIV vaccines and biologics prevention efforts for the foundation’s HIV team.
Historical Leadership
-

Melinda French Gates
Co-chair (2000-2024)
View profile: Melinda French GatesMelinda French Gates is a philanthropist, businesswoman, and global advocate for women and girls. She founded and co-chaired the Gates…
-

Warren Buffett
Trustee 2006-2021 (emeritus 2021)
View profile: Warren BuffettWarren Buffett helped shape our vision and developed strategies to address some of the world’s most challenging inequities.
-

William Gates Sr.
Co-chair 2000-2020 (d. 2020)
View profile: William Gates Sr.William H. Gates Sr. (d. 2020) guided the vision and strategic direction of the foundation and served as an advocate…
More about the foundation

Our role
For over 25 years, the Gates Foundation has been committed to fighting the greatest inequities in the world.

How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.

Our story
Learn about the origins of the foundation and the values that drive our work.



















